(Q45297248)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20358195%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

editorial

0 references

title

Key role of nuclear medicine in seeking biomarkers of Huntington's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20358195%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20358195%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Andrea Ciarmiello

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20358195%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

1 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20358195%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

number of pages

4

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20358195%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20358195%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20358195%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

1124-1127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20358195%20AND%20SRC:MED&resulttype=core&format=json

Rate of functional decline in Huntington's disease. Huntington Study Group

29 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-010-1439-8

Guidelines for the molecular genetics predictive test in Huntington's disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-010-1439-8

Abnormal morphology of peripheral cell tissues from patients with Huntington disease

21 January 2018

1 reference

12 December 2020

A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

1 reference

12 December 2020

Thalamic metabolism and symptom onset in preclinical Huntington's disease

1 reference

12 December 2020

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

1 reference

12 December 2020

Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals

1 reference

12 December 2020

Huntington disease: pathogenesis, biomarkers, and approaches to experimental therapeutics

1 reference

12 December 2020

Functional brain changes in presymptomatic Huntington's disease

1 reference

12 December 2020

Impaired PGC-1alpha function in muscle in Huntington's disease.

1 reference

12 December 2020

Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease

1 reference

12 December 2020

The platelet maximum number of A2A-receptor binding sites (Bmax) linearly correlates with age at onset and CAG repeat expansion in Huntington's disease patients with predominant chorea.

1 reference

12 December 2020

Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data

1 reference

12 December 2020

Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity

1 reference

12 December 2020

Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington's disease

1 reference

12 December 2020

Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load

1 reference

12 December 2020

Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course

1 reference

12 December 2020

Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins.

1 reference

12 December 2020

Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease

1 reference

12 December 2020

Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease.

1 reference

12 December 2020

Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients.

1 reference

12 December 2020

Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity

1 reference

12 December 2020

Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules

1 reference

12 December 2020

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

1 reference

12 December 2020

Longitudinal diffusion tensor imaging in Huntington's Disease

1 reference

12 December 2020

Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical "disconnection".

1 reference

12 December 2020

Early defect of transforming growth factor β1 formation in Huntington's disease.

1 reference

12 December 2020

Guidelines for the molecular genetics predictive test in Huntington's disease. International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea

1 reference

12 December 2020

DNA haplotype analysis of Huntington disease reveals clues to the origins and mechanisms of CAG expansion and reasons for geographic variations of prevalence

1 reference

12 December 2020

Key role of nuclear medicine in bringing imaging biomarkers into clinical practice

1 reference

12 December 2020

A systematic review of the treatment studies in Huntington's disease since 1990.

1 reference

12 December 2020

A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease

1 reference

12 December 2020

Beyond the brain: widespread pathology in Huntington's disease

1 reference

12 December 2020

Microglial activation in presymptomatic Huntington's disease gene carriers

1 reference

12 December 2020

Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood

1 reference

12 December 2020

Unified Huntington's disease rating scale: Reliability and consistency

1 reference

12 December 2020

A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats

1 reference

12 December 2020

10.1007/S00259-010-1439-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20358195%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

29 January 2020

1017465058

0 references

1 reference